15.482 Healthcare Finance
Covers the role of finance in the healthcare industry, with particular emphasis on the application of novel financing methods to facilitate drug discovery, clinical development, and greater patient access to high-cost therapies. Topics include basic financial analysis for the life-sciences professional, the historical financial risks and returns of the biotech and pharmaceutical industries, the mechanics of biotech startup financing, capital budgeting for pharmaceutical companies, and applications of financial engineering in drug royalty investment companies, biomedical megafunds, drug approval swaps, and life sciences investment banking.
15.482 will not be offered this semester. It will be available in the Spring semester, and will be instructed by A. Lo.
This class counts for a total of 9 credits. This is a graduate-level class.
You can find more information at the MIT + 15.482 - Google Search site.
© Copyright 2015 Yasyf Mohamedali